Masashi Tachibana Selected Research

adenovirus associated RNA (VA RNA)

1/2017	MicroRNA miR-27 Inhibits Adenovirus Infection by Suppressing the Expression of SNAP25 and TXN2.
1/2017	Enhanced Oncolytic Activities of the Telomerase-Specific Replication-Competent Adenovirus Expressing Short-Hairpin RNA against Dicer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masashi Tachibana Research Topics

Disease

16	Neoplasms (Cancer) 05/2022 - 09/2006
8	Infections 03/2020 - 07/2012
3	Inflammation (Inflammations) 01/2020 - 02/2005
2	Lymphoma (Lymphomas) 05/2022 - 01/2022
2	Communicable Diseases (Infectious Diseases) 02/2022 - 11/2012
2	Liver Failure 01/2017 - 05/2016
2	Liver Diseases (Liver Disease) 05/2016 - 01/2016
2	Insulin Resistance 05/2006 - 02/2004
1	Ebola Hemorrhagic Fever 02/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 02/2022
1	COVID-19 02/2022
1	Chemotherapy-Induced Febrile Neutropenia 01/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020
1	Colitis 01/2020
1	Retinoblastoma (Glioblastoma, Retinal) 08/2018
1	Melanoma (Melanoma, Malignant) 01/2018
1	Cachexia 01/2018
1	Hemophilia B (Haemophilia B) 09/2017
1	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 09/2017
1	Adenoviridae Infections (Adenovirus Infections) 01/2017
1	Virus Diseases (Viral Diseases) 01/2017
1	Cholestasis 01/2017
1	Acute Liver Failure (Fulminant Hepatic Failure) 05/2016
1	Circulating Neoplastic Cells 01/2016
1	Hypoxia (Hypoxemia) 05/2015
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2015
1	Drug-Related Side Effects and Adverse Reactions 02/2013
1	Fetal Death 06/2011

Drug/Important Bio-Agent (IBA)

4	PPAR gammaIBA 09/2006 - 02/2004
3	Single-Chain AntibodiesIBA 05/2022 - 01/2020
3	VaccinesIBA 02/2022 - 11/2012
3	CathepsinsIBA 05/2017 - 01/2015
2	Chimeric Antigen ReceptorsIBA 05/2022 - 01/2020
2	AntigensIBA 01/2020 - 11/2012
2	Immune Checkpoint InhibitorsIBA 01/2020 - 08/2018
2	Capsid Proteins (Capsid Protein)IBA 01/2018 - 01/2015
2	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2017 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 09/2017 - 05/2015
2	adenovirus associated RNA (VA RNA)IBA 01/2017 - 01/2017
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2022
1	2- amino- 4- ((3- (carboxymethyl)phenyl)(methyl)phosphono)butanoic acidIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2022
1	CytokinesIBA 01/2020
1	Interleukin-17 (Interleukin 17)IBA 01/2020
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2020
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2020
1	LigandsIBA 01/2020
1	Toll-Like Receptor 4IBA 08/2018
1	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 08/2018
1	B7-H1 AntigenIBA 08/2018
1	ArginaseIBA 08/2018
1	AntibodiesIBA 01/2018
1	ChemokinesIBA 01/2018
1	LY 341495IBA 01/2018
1	Neutralizing AntibodiesIBA 01/2018
1	Glutamine (L-Glutamine)FDA Link 01/2018
1	metabotropic glutamate receptor 2IBA 01/2018
1	Glutamic Acid (Glutamate)FDA Link 01/2018
1	HMGB1 Protein (HMG1)IBA 01/2018
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 09/2017
1	Liposomes (Liposome)IBA 05/2017
1	Antineoplastic Agents (Antineoplastics)IBA 05/2017
1	Indicators and Reagents (Reagents)IBA 05/2017
1	NucleosidesIBA 01/2017
1	Peptides (Polypeptides)IBA 01/2017
1	Member 11 Subfamily B ATP Binding Cassette TransporterIBA 01/2017
1	Bile Acids and Salts (Bile Acids)IBA 01/2017
1	MicroRNAs (MicroRNA)IBA 01/2017
1	entecavir FDA Link 01/2017
1	myrcludex-BIBA 01/2017
1	ThioredoxinsIBA 01/2017
1	SNARE Proteins (SNAREs)IBA 01/2017
1	EndoribonucleasesIBA 01/2017
1	Reverse Transcriptase InhibitorsIBA 01/2017
1	sodium-bile acid cotransporterIBA 01/2017
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 05/2016
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	Pharmaceutical PreparationsIBA 01/2016
1	Double-Stranded RNA (RNA, Double Stranded)IBA 05/2015
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2015
1	InterferonsIBA 01/2015
1	Interferon Type IIBA 01/2015
1	Transcription Factors (Transcription Factor)IBA 02/2013
1	DNA (Deoxyribonucleic Acid)IBA 11/2012
1	Interleukin-3 (Interleukin 3)IBA 07/2012
1	Immunoglobulin E (IgE)IBA 07/2012
1	Firefly LuciferasesIBA 06/2011
1	Red Fluorescent ProteinIBA 06/2011
1	2-chloro-5-nitrobenzanilideIBA 09/2006
1	T 0070907IBA 09/2006
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 09/2006

Therapy/Procedure

6	Therapeutics 01/2020 - 09/2006
2	Immunotherapy 01/2022 - 01/2020
1	Drug Therapy (Chemotherapy) 01/2022
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2020
1	Transplantation 05/2016
1	Injections 07/2012